
Loading, please wait...

Loading, please wait...

Brachial plexus injuries present significant challenges for functional recovery, often requiring complex nerve transfer surgeries. While surgical techniques have advanced, clinicians still face difficulties in tracking the underlying biological recovery. Recent research highlights how needle electromyography reinnervation monitoring provides a cost-effective and reproducible method to evaluate both axonal growth and cortical changes. This longitudinal study explores the utility of serial EMG in assessing these critical recovery markers.
Traumatic brachial plexus injuries often result in devastating loss of shoulder and elbow function. Consequently, surgeons perform neurotization or nerve transfers to bridge the gap in neural pathways. However, successful outcomes depend on more than just physical axonal regeneration. The brain must also undergo cortical plasticity to adapt to the new donor-recipient relationship. Although advanced neuroimaging can detect these brain changes, its high cost and technical complexity limit its daily clinical use.
Researchers conducted a longitudinal observational study involving 21 patients who underwent 34 proximal nerve transfers between 2012 and 2020. They performed serial electromyography at 3- to 9-month intervals over at least three years. Specifically, the team used dual-channel recordings to monitor spontaneous activity, motor unit potentials, and synkineses.
The results showed that functional success, defined as an MRC score of ≥3/5 with adequate range of motion, occurred in 58.8% of cases. Notably, patients who achieved success displayed early signs of reinnervation within 6.5 months on average. Furthermore, those with successful functional outcomes reached motor unit potential (MUP) stability significantly faster than those with poor results.
In addition to tracking axonal growth, needle electromyography serves as a window into the central nervous system. The study identified synkinetic activity as a crucial marker of neuroplasticity. These synkineses represent the brain's attempt to rewire neural pathways after nerve transfer. Therefore, monitoring these electrical signals allows clinicians to assess whether the patient is successfully integrating the new nerve source into functional movements.
Moreover, the findings suggest that the timing of MUP appearance is a strong predictor of ultimate strength. Clinicians can use these early markers to adjust rehabilitation protocols or consider secondary interventions if reinnervation appears delayed. Ultimately, this approach offers a practical way to bridge the gap between electrophysiological data and clinical functional scores.
Integrating serial needle electromyography into post-operative care provides invaluable data on both nerve regeneration and brain adaptation. By identifying synkineses and monitoring the speed of reinnervation, healthcare providers can better predict and support patient recovery. This method remains a highly accessible and effective tool for surgeons and neurologists managing complex brachial plexus reconstructions.
Early signs of reinnervation typically appear between 6 to 7 months post-surgery. However, the exact timing varies based on the distance between the donor nerve and the target muscle.
Synkineses are involuntary muscle contractions that occur alongside voluntary movements. In nerve transfers, they act as potential markers of neuroplasticity, indicating that the brain is adapting to the new neural connections.
Functional recovery requires the brain to learn how to control a muscle using a different donor nerve. Without this cortical adaptation, even successful physical nerve growth may not lead to coordinated functional movement.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Brušáková Š et al. Monitoring Reinnervation and Neuroplasticity After Neurotization Using Needle Electromyography. J Clin Neurophysiol. 2026 Feb 12. doi: 10.1097/WNP.0000000000001243. PMID: 41678273.
2. Bhandari PS et al. Surgical outcomes following nerve transfers in upper brachial plexus injuries. Indian J Plast Surg. 2009;42:150–60. doi: 10.4103/0970-0358.59272.
3. Sulaiman O et al. Nerve transfer surgery for adult brachial plexus injury: a 10-year experience at Louisiana State University. Neurosurgery. 2009.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This study explores needle electromyography as a reproducible tool to monitor reinnervation and cortical plasticity after nerve transfers for brachial plexu...
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today